CR 241220 175.00C (CR241220C175000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CR241220C175000

Watchlist

8.50
+2.16+34.07%

15min DelayTrading Nov 19 13:54 ET

8.50High7.50Low

Intraday

5D
Daily

News

These 4 Measures Indicate That Crane (NYSE:CR) Is Using Debt Reasonably Well
Simply Wall StNov 19 05:36 ET
China Approves Double-Crane Pharma Unit's Supplementary Drug Application for Eye Drops
MT NewswiresNov 19 00:49 ET
Stifel Downgrades Crane to Hold, Maintains Price Target to $176
BenzingaNov 18 09:14 ET · Ratings
Crane Analyst Ratings
BenzingaNov 18 09:11 ET · Ratings
Smiths Group (LSE:SMIN) Leverages John Crane and AI for Growth, Eyes Market Value Upside
Yahoo FinanceNov 17 20:09 ET
Syndax Wins FDA Approval for Leukemia Drug Revumenib
Seeking AlphaNov 15 17:45 ET

Comments

Insiders selling shares below current price and lack of purchases over the past year raises caution. Despite ownership, their selling activity suggests a lack of urgency to buy. However, company's earnings growth is positive.

Possible Bearish Signals With Crane Insiders Disposing Stock

Moomoo AI

Mar 13 08:04

Insiders selling shares below current price could indicate they believe shares are fully valued. Modest insider ownership suggests some alignment with other shareholders.

This Crane NXT Insider Reduced Their Stake By 10%

Moomoo AI

Feb 29 08:26

The growth in profits and high level of insider ownership in Crane makes it an appealing stock to keep an eye on. The alignment of goals between shareholders and management is seen as a positive sign.

Crane (NYSE:CR) Ticks All The Boxes When It Comes To Earnings Growth